Qube Research & Technologies Ltd Cuts Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its target price cut by JPMorgan Chase & Co. from $180.00 to $170.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the specialty pharmaceutical company’s stock. JPMorgan Chase & Co.‘s target price indicates a potential upside […]
PNC Financial Services Group Inc. cut its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 36.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,807 shares of the specialty pharmaceutical company’s stock after selling 2,737 shares during the quarter. PNC […]
Connor Clark & Lunn Investment Management Ltd Cuts Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Connor Clark & Lunn Investment Management Ltd Has $22 84 Million Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.